Halberd Co. (OTCMKTS:HALB – Get Free Report) saw a significant growth in short interest in October. As of October 15th, there was short interest totaling 157,854 shares. Based on an average daily volume of 1,826,875 shares, the days-to-cover ratio is currently 0.1 days.
Halberd Price Performance
HALB traded up $0.00 during trading on Friday, hitting $0.00. The company’s stock had a trading volume of 400 shares, compared to its average volume of 797,172. Halberd has a twelve month low of $0.00 and a twelve month high of $0.00.
About Halberd
Halberd Corporation is a biotechnology and medical-device company focused on developing technologies intended to remove harmful substances from the bloodstream and potentially improve the treatment of neurological and other serious medical conditions.
The company has described its research around extracorporeal blood-cleansing systems, which are designed to process blood outside the body and target substances such as inflammatory cytokines and other potentially damaging molecules. Halberd has indicated that its technology may have applications in conditions including traumatic brain injury, post-traumatic stress disorder and neurodegenerative diseases.
Halberd Corporation is headquartered in the United States and trades on the over-the-counter market under the symbol HALB.
Further Reading
- Five stocks we like better than Halberd
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Halberd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halberd and related companies with MarketBeat.com's FREE daily email newsletter.
